Cigna Group
CIdata completeness 88%10 fiscal years on fileCigna Group earns about 17% on invested capital, and has bought back 21% of its shares over 5 years. The applicable estimate puts fair value near $209.13 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $174.1B1 | $180.5B2 | $195.3B3 | $247.1B3 | $274.9B3 |
| Net income | $5.42B4 | $6.78B5 | $5.16B6 | $3.43B6 | $5.96B6 |
| Operating cash flow | $7.19B7 | $8.66B8 | $11.8B9 | $10.4B9 | $9.6B9 |
| Capital expenditure | — | — | — | — | — |
| Free cash flow (derived) | — | — | — | — | — |
| Total debt | $4.57B10 | $2.99B11 | $4.01B12 | $3.92B13 | $592M13 |
| Cash & equivalents | $5.08B14 | $5.92B15 | $7.82B16 | $7.55B17 | $7.68B17 |
| Diluted shares | 341.0M | 313.1M | 296.9M | 283.2M | 268.6M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $1,553.19 of net worth that earned you $221.81 last year, against $22.04 of debt.
It earned an average 17% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is down 21% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has fallen 87% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$5.42B
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001739940-24-000005 (Revenues)
- 10-K · period ending 2022-12-31 · accession 0001739940-25-000009 (Revenues)
- 10-K · period ending 2023-12-31 · accession 0001739940-26-000006 (Revenues)
- 10-K · period ending 2021-12-31 · accession 0001739940-24-000005 (ProfitLoss)
- 10-K · period ending 2022-12-31 · accession 0001739940-25-000009 (ProfitLoss)
- 10-K · period ending 2023-12-31 · accession 0001739940-26-000006 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001739940-24-000005 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001739940-25-000009 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001739940-26-000006 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001739940-23-000008 (CommercialPaper)
- 10-K · period ending 2022-12-31 · accession 0001739940-24-000005 (CommercialPaper)
- 10-K · period ending 2023-12-31 · accession 0001739940-25-000009 (CommercialPaper)
- 10-K · period ending 2024-12-31 · accession 0001739940-26-000006 (CommercialPaper)
- 10-K · period ending 2021-12-31 · accession 0001739940-23-000008 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001739940-24-000005 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001739940-25-000009 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001739940-26-000006 (CashAndCashEquivalentsAtCarryingValue)